Added to YB: 2025-10-29
Pitch date: 2025-09-11
STIM [bullish]
Neuronetics, Inc.
-48.84%
current return
Author Info
No bio for this author
Company Info
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Market Cap
$206.3M
Pitch Price
$3.44
Price Target
15.00 (+887%)
Dividend
N/A
EV/EBITDA
-9.35
P/E
-3.12
EV/Sales
2.52
Sector
Health Care Equipment and Supplies
Category
growth
Neuronetics, Inc. - $STIM
STIM: Leading TMS mental health therapy provider post-Greenbrook acquisition. 395 BMP clinics, $200M run-rate revenue by 2026 (+18% YoY). FDA-cleared for adolescent depression (+35% TAM). Policy tailwinds with RFK Jr./Dr. Oz favoring non-SSRI alternatives. 1.8x 2025 rev vs peer BWAY at 5.3x. Path to Q4 2025 cash flow positive. Target $15/share (~3x upside) on 5x revenue multiple.
Read full article (4 min)